Myelitis in neuromyelitis optica spectrum disorder: The long and the short of it

Eoin P. Flanagan; Brian G. Weinshenker

doi:10.1177/1352458517692888

Myelitis in neuromyelitis optica spectrum disorder: The long and the short of it

Eoin P. Flanagan, Brian G. Weinshenker

Neurology

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	360-361
Number of pages	2
Journal	Multiple Sclerosis
Volume	23
Issue number	3
DOIs	https://doi.org/10.1177/1352458517692888
State	Published - Mar 1 2017

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1177/1352458517692888

Cite this

@article{27e1b383d23a4015a8844f9e31d7b4cf,

title = "Myelitis in neuromyelitis optica spectrum disorder: The long and the short of it",

author = "Flanagan, {Eoin P.} and Weinshenker, {Brian G.}",

note = "Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Flanagan reports no disclosures relevant to this manuscript. Dr Weinshenker has received a research grant from the Guthy Jackson Foundation. He receives royalties from RSR, Oxford University, and MVZ Labor PD Dr. Volkmann und Kollegen GbR for a technology license related to a test for aquaporin-4 autoantibodies for diagnosis of neuromyelitis optica. He served on data safety monitoring committees for Novartis, Biogen-Idec, and Mitsubishi and serves on adjudication committees for MedImmune and Alexion pharmaceutical companies. He serves on editorial boards for the Canadian Journal of Neurological Sciences, Neurology, and Turkish Journal of Neurology.",

year = "2017",

month = mar,

day = "1",

doi = "10.1177/1352458517692888",

language = "English (US)",

volume = "23",

pages = "360--361",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "3",

}

TY - JOUR

T1 - Myelitis in neuromyelitis optica spectrum disorder

T2 - The long and the short of it

AU - Flanagan, Eoin P.

AU - Weinshenker, Brian G.

N1 - Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Flanagan reports no disclosures relevant to this manuscript. Dr Weinshenker has received a research grant from the Guthy Jackson Foundation. He receives royalties from RSR, Oxford University, and MVZ Labor PD Dr. Volkmann und Kollegen GbR for a technology license related to a test for aquaporin-4 autoantibodies for diagnosis of neuromyelitis optica. He served on data safety monitoring committees for Novartis, Biogen-Idec, and Mitsubishi and serves on adjudication committees for MedImmune and Alexion pharmaceutical companies. He serves on editorial boards for the Canadian Journal of Neurological Sciences, Neurology, and Turkish Journal of Neurology.

PY - 2017/3/1

Y1 - 2017/3/1

UR - http://www.scopus.com/inward/record.url?scp=85014868091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014868091&partnerID=8YFLogxK

U2 - 10.1177/1352458517692888

DO - 10.1177/1352458517692888

M3 - Editorial

AN - SCOPUS:85014868091

SN - 1352-4585

VL - 23

SP - 360

EP - 361

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 3

ER -

Myelitis in neuromyelitis optica spectrum disorder: The long and the short of it

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this